What is Avricore Health Inc. (AVCRF)?

Avricore Health Inc. (AVCRF) is a stock in the Healthcare sector, Medical - Diagnostics & Research industry. View full analysis on Stocks360.

What is the current price of AVCRF?

The current price of AVCRF is $0.00. Prices are updated in real time on Stocks360.

What is AVCRF's price-to-earnings (PE) ratio?

AVCRF's trailing twelve-month PE ratio is -2.84, based on current price and earnings per share data available on Stocks360.

What is AVCRF's market capitalization?

AVCRF's market capitalization is $81,032.00, placing it in the small-cap tier.

Avricore Health Inc. (AVCRF)

Stock analysis · OTC · Healthcare · Medical - Diagnostics & Research

$0.00

Market Cap

$81.03K

PE (TTM)

-2.84

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.32

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.08

Avg Volume

N/A

Volume

15.00K

Avricore Health Inc. (AVCRF) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $81.03K. Trailing PE -2.84. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $0.04 2026-10-29 · $0.00 (-97.98%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Avricore Health Inc.

Avricore Health Inc. is a Canadian company specializing in health data and immediate diagnostic technologies. Its core offering is HealthTab, a proprietary platform providing precise, lab-quality point-of-care testing specifically designed for pharmacy environments. The company boasts significant strategic alliances, notably with Shoppers Drug Marts and Abbott. Founded in 1996, the Vancouver, Canada-based enterprise previously operated as Vanc Pharmaceuticals Inc. before officially adopting the name Avricore Health Inc. in October 2018.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-2.84×
P/S (TTM)	32.73×
P/B	4.73×
PEG	0.12×
P/FCF (TTM)	-5.61×
EV / EBITDA	-4.40×
EV / Sales	28.00×
Earnings Yield	-34.38%
Free Cash Flow Yield	-17.84%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$5.41M
Revenue (TTM)	$193.04K
Net Income (TTM)	-$2.17M
Free Cash Flow (TTM)	-$1.13M
Net Debt	-$912.55K
Working Capital	$934.88K
Gross Margin	-36.75%
Operating Margin	-677.30%
Net Margin	-933.80%
Return on Equity	-241.33%
Return on Invested Capital	-117.83%